United OrthopedicROCO:4129 -2.64%81 Net Margin % is 8.64% as of Dec. 2025, which is 27% above its 10-year median of 6.80. GuruFocus rates ROCO:4129 with a GF Score™ of 81/100 and a GF Value™ of NT$123.47 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 817 Medical Devices & Instruments companies, United Orthopedic ranks better than 72.95% on this metric.
The historical rank and industry rank for United Orthopedic's Net Margin % or its related term are showing as below:
ROCO:4129'
s Net Margin % Range Over the Past 10 Years
Min: 2.03 Med: 6.8 Max: 10.6
Current: 9.95
ROCO:4129's Net Margin % is ranked better than 72.95% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs ROCO:4129: 9.95
United Orthopedic (ROCO:4129) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
United Orthopedic Net Margin % Related Terms
United Orthopedic Net Margin % Historical Data
* Premium members only.
The historical data trend for United Orthopedic's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4129 vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, United Orthopedic's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
United Orthopedic Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, United Orthopedic's Net Margin % distribution charts can be found below:
* The bar in red indicates where United Orthopedic's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Orthopedic (ROCO:4129) has a Net Margin % of 8.64% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on United Orthopedic and its competitors. This is 27% above median its historical median of 6.80. Over the past decade, United Orthopedic's Net Margin % has ranged from 2.03 to 10.60. According to the industry distribution chart, United Orthopedic ranks #221 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 27.1%.
Is United Orthopedic's Net Margin % too high?
United Orthopedic's current Net Margin % of 8.64% is 27% above median its 10-year median of 6.80. Over the past 10 years, this metric has ranged from a low of 2.03 to a high of 10.60. The Medical Devices & Instruments industry median Net Margin % is 2.05. United Orthopedic's value of 8.64% is 321.5% above this industry median. Based on the distribution chart, United Orthopedic ranks #221 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, United Orthopedic has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does United Orthopedic's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, United Orthopedic ranks #221 out of 817 companies for Net Margin %. This puts United Orthopedic in the upper half of its industry. The industry median Net Margin % is 2.05. United Orthopedic's value of 8.64% is 321.5% above this benchmark. Historically, United Orthopedic's own Net Margin % has ranged from 2.03 to 10.60 over the past decade. While the company's 10-year median is 6.80 vs. the industry median of 2.05, United Orthopedic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.05, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. United Orthopedic's current Net Margin % of 8.64% is 321.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on United Orthopedic and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. United Orthopedic's current Net Margin % is 8.64%, which is 27% above median its own 10-year median of 6.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Orthopedic stock overvalued right now?
Based on GuruFocus' analysis, United Orthopedic (ROCO:4129) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$123.47, compared to a current price of NT$91.20 — trading 26.1% below its estimated fair value. The current Net Margin % is 8.64%, which is 27% above median its 10-year median of 6.80 and 321.5% above the Medical Devices & Instruments industry median of 2.05. United Orthopedic's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For United Orthopedic (ROCO:4129), the current Net Margin % is 8.64% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is United Orthopedic (ROCO:4129) Overvalued in 2026?
Based on GuruFocus' analysis, United Orthopedic stock appears to be undervalued.
The current stock price of NT$91.20 is trading 26.1% below its estimated GF Value™ of NT$123.47.
GuruFocus considers United Orthopedic to be Modestly Undervalued.
Key valuation signals for ROCO:4129:
Net Margin %: 8.64% (27% above median its 10-year median of 6.80)
GF Value™: NT$123.47 vs. price of NT$91.20 (26.1% below fair value)
Industry Position: 321.5% above the Medical Devices & Instruments median (#221 of 817)
No single metric tells the full story. See the ROCO:4129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
United Orthopedic Corp is engaged in the research, development, production, manufacturing, and sales of orthopedic implants, orthopedic surgical instruments and manufacturing equipment, special metal and plastics materials, as well as the import and export of the aforementioned products. Its products include Hip System, Knee System, and Limb Salvage.
81GF Score
Get the complete analysis for ROCO:4129
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4129 has been successfully added to your 
